We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$243B
AUM Growth
+$27.2B
Cap. Flow
+$15.3B
Cap. Flow %
6.3%
Top 10 Hldgs %
14.51%
Holding
8,546
New
751
Increased
3,655
Reduced
3,102
Closed
634

Sector Composition

Rank Sector Weight
1 Financials 7.78%
2 Technology 7.19%
3 Healthcare 5.6%
4 Industrials 5.06%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNMP
7551
DELISTED
Evolve Transition Infrastructure LP
SNMP
$2K ﹤0.01%
6
OIG
7552
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$2K ﹤0.01%
15
-23
-61% -$2.69K
NVCN
7553
DELISTED
Neovasc Inc.
NVCN
0
SMTS
7554
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$2K ﹤0.01%
+636
New +$1.56K
CTEK
7555
DELISTED
CynergisTek, Inc.
CTEK
$2K ﹤0.01%
466
-588
-56% -$2.09K
CTXRW
7556
DELISTED
Citius Pharmaceuticals, Inc. Warrant
CTXRW
$2K ﹤0.01%
4,265
+1,100
+35% +$760
SGLBW
7557
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
$2K ﹤0.01%
+3,556
New +$1.59K
PAVMW
7558
DELISTED
PAVmed Inc. Warrant
PAVMW
$2K ﹤0.01%
+3,949
New +$4.51K
SBBP
7559
DELISTED
Strongbridge Biopharma plc.
SBBP
$2K ﹤0.01%
264
-2,576
-91% -$16.1K
MDLY
7560
DELISTED
Medley Management Inc
MDLY
$2K ﹤0.01%
29
+12
+71% +$748
TLRA
7561
DELISTED
Telaria, Inc.
TLRA
$2K ﹤0.01%
+613
New +$2.61K
SNOAW
7562
DELISTED
Sonoma Pharmaceuticals, Inc. Warrants
SNOAW
$2K ﹤0.01%
3,707
+255
+7% +$97
FTNW
7563
DELISTED
FTE Networks, Inc.
FTNW
$2K ﹤0.01%
+153
New +$1.62K
SKYS
7564
DELISTED
Sky Solar Holdings, Ltd.
SKYS
$2K ﹤0.01%
460
-1,025
-69% -$4.26K
DEST
7565
DELISTED
Destination Maternity Corporation
DEST
$2K ﹤0.01%
652
+317
+95% +$798
NVLN
7566
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$2K ﹤0.01%
724
+188
+35% +$904
OASM
7567
DELISTED
Oasmia Pharmaceutical AB
OASM
$2K ﹤0.01%
2,039
-1,602
-44% -$1.54K
WYDE
7568
DELISTED
ProShares CDS Short North American HY Credit ETF
WYDE
$2K ﹤0.01%
+50
New +$1.63K
JASNW
7569
DELISTED
Jason Industries, Inc.
JASNW
$2K ﹤0.01%
75,491
+52,900
+234% +$1.25K
VISL
7570
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$2K ﹤0.01%
1
-9
-90% -$17.4K
ESES
7571
DELISTED
Eco-Stim Energy Solutions Inc. Common Stock
ESES
$2K ﹤0.01%
1,627
-4,252
-72% -$6K
RSLS
7572
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
$2K ﹤0.01%
+1
New +$3.31K
NWY
7573
DELISTED
New York & Co Inc
NWY
$2K ﹤0.01%
853
-1,617
-65% -$3.48K
ELECW
7574
DELISTED
Electrum Special Acquisition Corporation
ELECW
$2K ﹤0.01%
+3,700
New +$1.4K
OACQW
7575
DELISTED
Origo Acquisition Corporation Warrants
OACQW
$2K ﹤0.01%
3,500
+2,500
+250% +$924

Similar funds

UBS Group's Q4 2017 Portfolio in Review

As of Q4 2017, UBS Group held 8,546 positions worth $243B, up 13% from $216B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group deployed $15.3B of net new capital in Q4 2017, opening 751 new positions and adding to 3,655 existing holdings. Its largest new stake was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, up from 7.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.22B trimmed.

  • UBS Group's largest Q4 2017 buy was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.
  • UBS Group added most to Apple in Q4 2017, an estimated $602M increase.
  • UBS Group's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.22B.
  • UBS Group fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $139M.
  • UBS Group's ten largest holdings make up 15% of its $243B portfolio in Q4 2017.
  • UBS Group opened 751 new positions and closed 634 in Q4 2017.
  • UBS Group's portfolio value rose 13% quarter-over-quarter to $243B.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.